225 related articles for article (PubMed ID: 26499463)
21. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma.
Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F
Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673
[TBL] [Abstract][Full Text] [Related]
22. CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma.
He KF; Zhang L; Huang CF; Ma SR; Wang YF; Wang WM; Zhao ZL; Liu B; Zhao YF; Zhang WF; Sun ZJ
Biomed Res Int; 2014; 2014():838632. PubMed ID: 24883329
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
[TBL] [Abstract][Full Text] [Related]
24. Gli1 expression in cancer stem-like cells predicts poor prognosis in patients with lung squamous cell carcinoma.
Cui Y; Cui CA; Yang ZT; Ni WD; Jin Y; Xuan YH
Exp Mol Pathol; 2017 Apr; 102(2):347-353. PubMed ID: 28286162
[TBL] [Abstract][Full Text] [Related]
25. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
26. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
[TBL] [Abstract][Full Text] [Related]
27. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
[TBL] [Abstract][Full Text] [Related]
28. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
29. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma.
Chen MK; Cai MY; Luo RZ; Tian X; Liao QM; Zhang XY; Han JD
Br J Dermatol; 2015 Jan; 172(1):111-9. PubMed ID: 24975674
[TBL] [Abstract][Full Text] [Related]
32. Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
Chen PX; Li QY; Yang Z
Pathol Oncol Res; 2015 Sep; 21(4):1133-40. PubMed ID: 25971681
[TBL] [Abstract][Full Text] [Related]
33. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
34. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
[TBL] [Abstract][Full Text] [Related]
35. SOX2 and ALDH1 as Predictors of Operable Breast Cancer.
Shima H; Kutomi G; Satomi F; Maeda H; Hirohashi Y; Hasegawa T; Mori M; Torigoe T; Takemasa I
Anticancer Res; 2016 Jun; 36(6):2945-53. PubMed ID: 27272809
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
37. Expression of Sox2 in cervical squamous cell carcinoma.
Yang Z; Pan X; Gao A; Zhu W
J BUON; 2014; 19(1):203-6. PubMed ID: 24659665
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z
Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023
[TBL] [Abstract][Full Text] [Related]
39. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
